恆康醫療(002219.SZ):控股股東闕文彬擬放棄12.59%股份對應全部表決權
格隆匯3月30日丨恆康醫療(002219.SZ)公佈,公司於2020年3月30日接到公司控股股東闕文彬(“委託人”)、中企匯聯投資管理(北京)有限公司(“中企匯聯”或“受託人一”)以及五礦金通股權投資基金管理有限公司(“五礦金通”或“受託人二”)通知,獲悉委託人與受託人一、受託人二於2020年3月30日分別簽署了《合作協議》,已經各方簽字生效。
根據《合作協議》,闕文彬在與宋麗華、高洪濱的《投票權委託協議》及《投票權委託協議之補充協議》到期之日(2020年4月15日),將:
闕文彬放棄佔恆康醫療總股本12.59%的股份即2.35億股對應的全部表決權、提名和提案權、參會權、監督建議權、知情權以及除收益權和處置股份權利之外的其他權利。
闕文彬將其持有的公司3.71億股股份對應的表決權委託給中企匯聯行使,約佔公司總股本的19.90%,中企匯聯同意接受闕文彬的委託。同時,闕文彬將其持有的公司1.87億股股份對應的表決權委託給五礦金通行使,約佔公司總股本的10%,五礦金通同意接受闕文彬的委託。
此次《合作協議》簽署前,闕文彬持有公司7.93億股股份,佔公司總股本的42.49%,為公司的控股股東。此次權益變動後,闕文彬持股7.93億股,持股比例42.49%,放棄表決權股數2.35億股,放棄表決權比例12.59%;中企匯聯投資管理(北京)有限公司擁有表決權股數3.71億股,擁有表決權比例19.90%;五礦金通股權投資基金管理有限公司擁有表決權股數1.87億股,擁有表決權比例10%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.